This toolbox was developed in 2020 for the World Health Organisation COVID-19 Research Roadmap and provides a synthesis of key action points from the WHO GPP-EP guidelines. This “how to” guide gives an overview, tips and resources and will be updated as new resources are completed and approved.

19th May 2021 • comment

This toolbox was developed for the World Health Organisation COVID-19 Research Roadmap and shares information on establishing and working with different types of Community Advisory Boards/Groups (CAB/Gs) in the context of COVID-19 clinical studies.

19th May 2021 • comment

Evaluation report from the Wellcome Trust's Sciart funding programme

6th April 2016 • comment

This podcast features the team who led the EBOVAC-Salone study at London School of Hygiene and Tropical Medicine discussing the role community engagement played within clinical trials

23rd January 2019 • comment

This 7 module course offers comprehensive training exploring the wide range of ethical issues faced by health professionals and policy makers working in the context of epidemics/pandemics and disaster situations, focusing primarily on the key areas of research, surveillance and patient care.

22nd January 2019 • comment
22nd January 2019 • comment
14th January 2019 • comment
14th January 2019 • comment
7th January 2019 • comment
7th January 2019 • comment

This paper briefly summarises the discussion of a committee which aimed to assess clinical trials conducted in Guinea, Sierra Leone and Liberia during the 2014-15 Ebola outbreak in West Africa.

20th November 2018 • comment

This article argues for a conceptual shift away from the static, singular term ‘trial community’ towards ‘experimental publics’. The authors observe that the term ‘community’ is often employed uncritically and assumes that ‘communities’ pre-exist research; that they are timeless and undifferentiated wholes. ‘Experimental publics’, by contrast, are dynamic, multiple, and impermanent in nature.

22nd October 2018 • comment